J&J Medtech Sales Disappoint, Considers Orthopedic Spinoff

Johnson & Johnson reported a 2.5% rise in medical technology sales, missing estimates, and is leaning toward a spinoff of its orthopedics business. The company's medtech performance disappointed investors, with the potential spinoff seen as a strategic move to streamline operations, according to Bloomberg.